Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy

Owing to its pH-sensitive property and chelating Cu<sup>2+</sup> effect, poly(methacrylate citric acid) (PCA) can be utilized as a dual functional nanocarrier to construct a nanodelivery system. Negatively charged carboxyl groups can interact with positively charged antineoplastic drugs...

Full description

Bibliographic Details
Main Authors: Bo Yu, Yiping Shen, Xuejie Zhang, Lijuan Ding, Zheng Meng, Xiaotong Wang, Meihua Han, Yifei Guo, Xiangtao Wang
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/9/1765
_version_ 1797483660473008128
author Bo Yu
Yiping Shen
Xuejie Zhang
Lijuan Ding
Zheng Meng
Xiaotong Wang
Meihua Han
Yifei Guo
Xiangtao Wang
author_facet Bo Yu
Yiping Shen
Xuejie Zhang
Lijuan Ding
Zheng Meng
Xiaotong Wang
Meihua Han
Yifei Guo
Xiangtao Wang
author_sort Bo Yu
collection DOAJ
description Owing to its pH-sensitive property and chelating Cu<sup>2+</sup> effect, poly(methacrylate citric acid) (PCA) can be utilized as a dual functional nanocarrier to construct a nanodelivery system. Negatively charged carboxyl groups can interact with positively charged antineoplastic drugs through electrostatic interaction to form stable drug nanoparticles (NPs). Through drug experimental screening, doxorubicin (DOX) was selected as the model drug, PCA/DOX NPs with a diameter of 84 nm were prepared, and the drug-loading content was 68.3%. PCA/DOX NPs maintained good stability and a sustained release profile. Cell experiments presented that PCA/DOX NPs could inhibit effectively the growth of 4T1 cells; the IC<sub>50</sub> value was decreased by approximately 15-fold after incubation for 72 h. The cytotoxicity toward H9C2 was decreased significantly. Moreover, based on its ability to efficiently adsorb copper ions, PCA showed good vascular growth inhibition effect in vitro. Furthermore, animal experiments showed that PCA/DOX NPs presented stronger anticancer effects than DOX; the tumor inhibition rate was increased by 1.5-fold. Myocardial toxicity experiments also confirmed that PCA reduced the cardiotoxicity of DOX. In summary, PCA/DOX NPs show good antitumor efficacy and low toxicity, and have good potential for clinical application.
first_indexed 2024-03-09T22:51:12Z
format Article
id doaj.art-4405587741234de592c2c98875b30eda
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T22:51:12Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-4405587741234de592c2c98875b30eda2023-11-23T18:20:05ZengMDPI AGPharmaceutics1999-49232022-08-01149176510.3390/pharmaceutics14091765Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor TherapyBo Yu0Yiping Shen1Xuejie Zhang2Lijuan Ding3Zheng Meng4Xiaotong Wang5Meihua Han6Yifei Guo7Xiangtao Wang8Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, ChinaInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, ChinaInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, ChinaInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, ChinaInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, ChinaInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, ChinaInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, ChinaInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, ChinaInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, ChinaOwing to its pH-sensitive property and chelating Cu<sup>2+</sup> effect, poly(methacrylate citric acid) (PCA) can be utilized as a dual functional nanocarrier to construct a nanodelivery system. Negatively charged carboxyl groups can interact with positively charged antineoplastic drugs through electrostatic interaction to form stable drug nanoparticles (NPs). Through drug experimental screening, doxorubicin (DOX) was selected as the model drug, PCA/DOX NPs with a diameter of 84 nm were prepared, and the drug-loading content was 68.3%. PCA/DOX NPs maintained good stability and a sustained release profile. Cell experiments presented that PCA/DOX NPs could inhibit effectively the growth of 4T1 cells; the IC<sub>50</sub> value was decreased by approximately 15-fold after incubation for 72 h. The cytotoxicity toward H9C2 was decreased significantly. Moreover, based on its ability to efficiently adsorb copper ions, PCA showed good vascular growth inhibition effect in vitro. Furthermore, animal experiments showed that PCA/DOX NPs presented stronger anticancer effects than DOX; the tumor inhibition rate was increased by 1.5-fold. Myocardial toxicity experiments also confirmed that PCA reduced the cardiotoxicity of DOX. In summary, PCA/DOX NPs show good antitumor efficacy and low toxicity, and have good potential for clinical application.https://www.mdpi.com/1999-4923/14/9/1765poly(methacrylate citric acid)doxorubicinpH sensitivechelating Cu<sup>2+</sup> effect
spellingShingle Bo Yu
Yiping Shen
Xuejie Zhang
Lijuan Ding
Zheng Meng
Xiaotong Wang
Meihua Han
Yifei Guo
Xiangtao Wang
Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy
Pharmaceutics
poly(methacrylate citric acid)
doxorubicin
pH sensitive
chelating Cu<sup>2+</sup> effect
title Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy
title_full Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy
title_fullStr Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy
title_full_unstemmed Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy
title_short Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy
title_sort poly methacrylate citric acid as a dual functional carrier for tumor therapy
topic poly(methacrylate citric acid)
doxorubicin
pH sensitive
chelating Cu<sup>2+</sup> effect
url https://www.mdpi.com/1999-4923/14/9/1765
work_keys_str_mv AT boyu polymethacrylatecitricacidasadualfunctionalcarrierfortumortherapy
AT yipingshen polymethacrylatecitricacidasadualfunctionalcarrierfortumortherapy
AT xuejiezhang polymethacrylatecitricacidasadualfunctionalcarrierfortumortherapy
AT lijuanding polymethacrylatecitricacidasadualfunctionalcarrierfortumortherapy
AT zhengmeng polymethacrylatecitricacidasadualfunctionalcarrierfortumortherapy
AT xiaotongwang polymethacrylatecitricacidasadualfunctionalcarrierfortumortherapy
AT meihuahan polymethacrylatecitricacidasadualfunctionalcarrierfortumortherapy
AT yifeiguo polymethacrylatecitricacidasadualfunctionalcarrierfortumortherapy
AT xiangtaowang polymethacrylatecitricacidasadualfunctionalcarrierfortumortherapy